Northwestern Mutual Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$644	–	4189
2025 Q3	$644	Buy	+25	New	+$614	﹤0.01%	3611
2024 Q2	–	Sell	-1	Closed	-$29	–	3733
2024 Q1	$29	Hold	1	–	–	﹤0.01%	3498
2023 Q4	$34	Buy	+1	New	+$29	﹤0.01%	3415
2023 Q2	–	Sell	-5	Closed	-$204	–	3535
2023 Q1	$204	Buy	+5	New	+$199	﹤0.01%	3184
2022 Q3	–	Sell	-16	Closed	-$1K	–	3317
2022 Q2	$1K	Buy	+16	New	+$1.05K	﹤0.01%	3062
2021 Q3	–	Sell	-36	Closed	-$2K	–	3161
2021 Q2	$2K	Buy	+36	New	+$2.28K	﹤0.01%	2824
2019 Q4	–	Sell	-29	Closed	-$1K	–	2562
2019 Q3	$1K	Buy	+29	New	+$1.16K	﹤0.01%	2381
2018 Q3	–	Sell	-11	Closed	–	–	2591
2018 Q2	$0	Buy	+11	New	+$380	﹤0.01%	2462
2017 Q1	–	Sell	-10	Closed	–	–	2294
2016 Q4	$0	Buy	+10	New	+$334	﹤0.01%	2467
2016 Q3	–	Sell	-72	Closed	-$2K	–	2284
2016 Q2	$2K	Buy	+72	New	+$3.54K	﹤0.01%	1850
2016 Q1	–	Sell	-300	Closed	-$23K	–	2244
2015 Q4	$23K	Buy	+300	New	+$17K	﹤0.01%	970
2015 Q1	–	Sell	-29	Closed	-$3K	–	1739
2014 Q4	$3K	Buy	+29	New	+$2.74K	﹤0.01%	1427

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's PCRX Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of Pacira BioSciences (PCRX) in Q4 2025, closing a stake of 25 shares — an estimated $644 sold.

Northwestern Mutual Wealth Management first reported a position in PCRX in Q4 2014 and held it in 12 quarters. The position peaked at $23K in Q4 2015. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2025.

Northwestern Mutual Wealth Management reported no remaining Pacira BioSciences position as of Q4 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 25 Pacira BioSciences shares in Q4 2025, an estimated $644.
Northwestern Mutual Wealth Management first reported a position in Pacira BioSciences in Q4 2014 and held it in 12 quarters.
Northwestern Mutual Wealth Management's Pacira BioSciences position peaked at $23K in Q4 2015.
260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.